Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMID 3514652)

Published in J Clin Endocrinol Metab on May 01, 1986

Authors

S Lillioja, D M Mott, J K Zawadzki, A A Young, W G Abbott, C Bogardus

Associated clinical trials:

Insulin Secretory Defects in Pima Indians at High Risk for NIDDM | NCT00410800

Articles citing this

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest (1989) 3.03

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96

Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest (1990) 2.50

Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol (2010) 1.92

Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest (1988) 1.42

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest (1990) 1.36

Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest (1989) 1.34

Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest (1994) 1.26

Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest (1987) 1.25

Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. J Clin Invest (1993) 1.15

Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity. J Clin Invest (1988) 1.11

Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest (1998) 1.09

Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest (1990) 1.09

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest (1993) 1.06

Higher energy expenditure in humans predicts natural mortality. J Clin Endocrinol Metab (2011) 1.01

Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab (2008) 0.95

Defective insulin response of phosphorylase phosphatase in insulin-resistant humans. J Clin Invest (1992) 0.82

Fasting hyperglycemia predicts lower rates of weight gain by increased energy expenditure and fat oxidation rate. J Clin Endocrinol Metab (2015) 0.82

Metabolic abnormalities and cardiovascular risk factors in children with myositis. J Pediatr (2009) 0.81

Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin-resistant humans. J Clin Invest (1991) 0.81

Determinants, consequences and prevention of childhood overweight and obesity: An Indian context. Indian J Endocrinol Metab (2014) 0.78

Activation of skeletal muscle casein kinase II by insulin is not diminished in subjects with insulin resistance. J Clin Invest (1991) 0.78

Articles by these authors

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest (1999) 7.35

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89

Changing habits to delay diabetes. N Engl J Med (2001) 5.30

Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest (1986) 5.18

Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes (1997) 4.17

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia (2000) 3.63

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41

The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med (1988) 3.36

Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med (1988) 3.19

Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96

Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev (1988) 2.64

Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest (1990) 2.63

Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest (1984) 2.62

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care (2001) 2.33

An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest (1998) 2.18

Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia (2002) 2.08

Energy metabolism in African Americans: potential risk factors for obesity. Am J Clin Nutr (1999) 2.03

Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia (2005) 2.03

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest (1984) 2.03

Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest (1991) 2.02

Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes (1999) 1.98

Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr (1989) 1.96

Familial dependence of the resting metabolic rate. N Engl J Med (1986) 1.94

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res (2001) 1.89

Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol (1985) 1.89

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85

Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest (1987) 1.83

Body weight gain in free-living Pima Indians: effect of energy intake vs expenditure. Int J Obes Relat Metab Disord (2003) 1.79

Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet (1998) 1.78

Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr (1991) 1.77

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes (2000) 1.73

A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia (1995) 1.70

In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes (1987) 1.70

Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med (1991) 1.68

Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.54

An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest (1995) 1.51

Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord (1999) 1.51

Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. J Clin Endocrinol Metab (2000) 1.49

Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol Genet Metab (2002) 1.48

Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia (2005) 1.47

Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J Clin Invest (1985) 1.44

Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation (1986) 1.42

Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet (1989) 1.41

Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem (1996) 1.41

Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest (1995) 1.41

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab (1991) 1.40

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int J Obes (Lond) (2006) 1.35

Effect of muscle glycogen depletion on in vivo insulin action in man. J Clin Invest (1983) 1.35

Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab (2001) 1.32

Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest (1984) 1.32

Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab (1991) 1.30

Deformable models with parameter functions for cardiac motion analysis from tagged MRI data. IEEE Trans Med Imaging (1996) 1.29

Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum (2001) 1.27

Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol Genet Metab (1998) 1.27

Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes (1991) 1.27

Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest (1994) 1.26

Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest (1987) 1.25

Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet (1997) 1.25

Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction. Diabetes (1988) 1.23

Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes (2001) 1.23

Short-term energy balance: relationship with protein, carbohydrate, and fat balances. Am J Physiol (1988) 1.23

A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia (2009) 1.22

Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab (1995) 1.21

Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord (2004) 1.19

Spontaneous physical activity and obesity: cross-sectional and longitudinal studies in Pima Indians. Am J Physiol (1992) 1.19